|
Market Cap (3-Jul) $59,685,164 (840th) |
Close (30-Jun) $0.86 |
Volume (30-Jun) 64,140 |
Shortsold (19-Jun) 737,517 (0.45%) (320th) |
|
52w High $1.12 |
52w Low $0.285 |
P/E - |
EPS -0.06 |
PIQ released this announcement to the ASX on 28 July 2021, 18:00. The announcement is not marked as price sensitive, and is 2 page(s) in length and 576.22kb in size.
You can view all announcements from PIQ and see how they appear on a price chart on the announcements page.
At the date of this announcement, PIQ was 0.000% short sold according to ASIC data. It was ranked the 665th most shorted stock on the ASX. It is now ranked as the 320th most shorted stock on the ASX with 0.451% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from PIQ | |
|---|---|
| Sonic Healthcare USA signs licence for PromarkerD in the US | 10 May 2023, 11:41 |
| Trading Halt | 8 May 2023, 9:15 |
| World Endometriosis Congress - New diagnostic test showcased | 5 May 2023, 8:15 |
| Manufacturing update and clarification of Abcam engagement | 28 July 2021, 18:00 |
| Proteomics engages Abcam to manufacture PromarkerD reagents | 22 July 2021, 9:07 |
| Notification regarding unquoted securities - PIQ | 20 July 2021, 16:24 |
| Issue of Equity Incentives to Key Management Personnel | 20 July 2021, 16:16 |
You must be logged in to post a reply.
Proteomics International Laboratories 